involving more than 20,000 patients with osteoarthritis to examine cardiovascular outcomes against traditional NSAIDs. Many patients are receiving these agents instead of COX2-selective inhibitors ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback